Gilead Sciences Inc
(BUE:GILD)
ARS
26600
125 (0.47%)
Market Cap: 111.51 Tn
Enterprise Value: 131.94 Tn
PE Ratio: 110.08
PB Ratio: 6.15
GF Score: 52/100 
Gilead Sciences Inc at Evercore ISI HealthCONx Conference Transcript
Dec 02, 2020 / 04:20PM GMT
Release Date Price:
ARS2252.5
(-1.94%)
Umer Raffat
Evercore ISI Institutional Equities, Research Division - Senior MD & Senior Analyst of Equity Research
Excellent. Listen guys, thank you so much for joining us. It's a huge pleasure to have a broad representation from the Gilead management join us, from the R&D side, the commercial side, the Investor Relations side. Thank you guys so much for joining us.
Johanna Mercier
Gilead Sciences, Inc. - Chief Commercial Officer
Thrilled to be here. Thanks, Um.
Questions & Answers
Umer Raffat
Evercore ISI Institutional Equities, Research Division - Senior MD & Senior Analyst of Equity Research
Fantastic.
Merdad V. Parsey
Gilead Sciences, Inc. - Chief Medical Officer
Thank you.
Umer Raffat
Evercore ISI Institutional Equities, Research Division - Senior MD & Senior Analyst of Equity Research
So just as we get started, I thought given the way this year evolved, maybe we should start off on COVID,
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers